Učitavanje...
Indomethacin for symptomatic patent ductus arteriosus in preterm infants
BACKGROUND: Symptomatic patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. In these infants, prophylactic use of indomethacin, a non‐selective cyclooxygenase inhibitor, has demonstrated short‐term clinical benefits. The effect of indomethacin in preterm inf...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2021
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095061/ https://ncbi.nlm.nih.gov/pubmed/33448032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013133.pub2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|